.png)
.png)
Prof.
University of Cologne, Faculty of Medicine and University Hospital Cologne, Germany
Disclosure(s): Abbott: Honoraria; Abbvie: Advisor/Consultant; Actelion: Board Member; Al-Jazeera Pharmaceuticals: Honoraria; Allecra Therapeutics: Board Member; Amplyx: Advisor/Consultant, Grant/Research Support; Astellas: Honoraria; Basilea: Advisor/Consultant, Grant/Research Support; Biocon: Advisor/Consultant; Biosys: Advisor/Consultant; BMBF: Grant/Research Support; Cidara: Advisor/Consultant, Board Member, Expert Testimony, Grant/Research Support; CoRe Consulting: Stocks/Bonds; Da Volterra: Advisor/Consultant; DLR: Grant/Research Support; DZIF: Grant/Research Support; Entasis: Board Member; EU Directorate-General for Resarch and Innovation: Grant/Research Support; F2G: Grant/Research Support; German Patent and Trade Mark Office: German patent (DE 10 2021 113 007.7); Gilead: Advisor/Consultant, Grant/Research Support; Grupo Biotoscana/United Medical/Knight: Honoraria; Hikma: Honoraria; IQVIA: Board Member; Janssen: Board Member; Matinas: Advisor/Consultant, Grant/Research Support; MedPace: Advisor/Consultant, Grant/Research Support; MedScape: Honoraria; MedUpdate: Honoraria; Menarini: Advisor/Consultant; Merck/MSD: Grant/Research Support, Honoraria; Molecular Partners: Advisor/Consultant; MSG-ERC: Advisor/Consultant; Mundipharma: Grant/Research Support; Mylan: Honoraria; Noxxon: Advisor/Consultant; Octapharma: Advisor/Consultant, Grant/Research Support; Paratek: Board Member; Pardes: Advisor/Consultant; Pfizer: Grant/Research Support, Honoraria; Projektträger Jülich: Grant/Research Support; PSI: Advisor/Consultant, Board Member; Pulmocide: Board Member; Scynexis: Advisor/Consultant, Grant/Research Support; Seres: Advisor/Consultant; Shionogi: Board Member; Wiley (Blackwell): Editor-in-Chief, Mycoses